The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Combination of the PARPi and ARSi in advanced castration resistant prostate cancer: a review of the recent phase III trials”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Hamza Mallah, Sina Soultani, Zania Diabasana, Véronique Lindner, Philippe Barthélémy, Ysia Idoux-Gillet, Thierry Massfelder. PARP Inhibitors Combined with Abiraterone Overcome Resistance in Metastatic Castration-Resistant Prostate Cancer Independently of Androgen Receptor, Cancers. 2026; 18: 560. https://doi.org/10.3390/cancers18040560 |
|
2 |
2026 |
Arne Blickle, Sebastian Ganz, Caroline Burgard, Mark Bartholomä, Stephan Maus, Moritz B. Bastian, Tilman Speicher, Andrea Schaefer-Schuler, Sven Petto, Samer Ezziddin, Florian Rosar. Health-related Quality of Life in mCRPC Patients Undergoing [161Tb]Tb-PSMA-617 Radioligand Therapy: Pilot Experience From a Real-World Setting, Nuclear Medicine and Molecular Imaging. 2026; https://doi.org/10.1007/s13139-026-01032-5 |
|
3 |
2024 |
Timur Saliev, Nurgulim Akhmad, Saule Altynbekova, Maral Nogaeva, Aigul Tazhieva, Zaure Dushimova. Role of ethnic and genetic factors in the development of prostate cancer (Review), World Academy of Sciences Journal. 2024; 7: 13. https://doi.org/10.3892/wasj.2024.301 |